[144] D.R. Horton Inc. SEC Filing

Rhea-AI Filing Summary

A Form 144 filing by D.R. Horton indicates a proposed sale of 2,150 shares of common stock with an aggregate market value of $274,552. The sale is planned to be executed through Charles Schwab & Co. on the NYSE, with an approximate sale date of June 24, 2025.

The shares to be sold were acquired through multiple restricted stock lapses:

• 254 shares on 11/26/2022
• 470 shares on 11/26/2023
• 763 shares on 01/26/2024
• 663 shares on 01/26/2025

All shares were received as equity compensation from the company. The total outstanding shares of D.R. Horton common stock are 307,181,294. No other securities were reported as sold by the filer during the past 3 months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2150	274552.00	307181294	06/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/26/2022	Restricted Stock Lapse	D.R. Horton, Inc.			254	11/26/2022	Equity Compensation
Common	11/26/2023	Restricted Stock Lapse	D.R. Horton, Inc.			470	11/26/2023	Equity Compensation
Common	01/26/2024	Restricted Stock Lapse	D.R. Horton, Inc.			763	01/26/2024	Equity Compensation
Common	01/26/2025	Restricted Stock Lapse	D.R. Horton, Inc.			663	01/26/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many DHI shares are being sold according to the Form 144 filing from June 2025?

According to the Form 144 filing, 2,150 shares of DHI common stock are proposed to be sold through Charles Schwab & Co., Inc., with an aggregate market value of $274,552.00.

What is the source of DHI shares being sold in this Form 144?

The shares being sold came from multiple restricted stock lapses: 254 shares from 11/26/2022, 470 shares from 11/26/2023, 763 shares from 01/26/2024, and 663 shares from 01/26/2025, all acquired as equity compensation from D.R. Horton, Inc.

What was the total number of DHI shares outstanding as reported in the June 2025 Form 144?

According to the Form 144 filing, D.R. Horton had 307,181,294 shares outstanding at the time of the filing.

When is the planned sale date for the DHI shares in this Form 144?

The approximate date of sale is listed as 06/24/2025 on the New York Stock Exchange (NYSE).

Has the insider selling these DHI shares made any other sales in the past 3 months?

According to the Form 144 filing section 'Securities Sold During The Past 3 Months', there were no other sales to report by this person during the previous 3-month period.